NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
06/02/2026 09:00
NASDAQ TRADE HALT SGP.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on SpyGlass Pharma
See all newsBrief: Spyglass Pharma Announces Positive 4-Year Data From First-In-Human Trial Of BIM-Iol System
SpyGlass Pharma Q2 net loss widens on higher expenses
Brief: Spyglass Pharma Inc - BIM-Iol System Phase 3 Trial Enrollment Expected To Complete In 2027
Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO (updated)
NASDAQ RESUMED AT 01:46 PM